NCT00142545View on ClinicalTrials.gov

"Long Term Safety and Efficacy of SC Apomorphine in Treatment of Off Episodes in Late-Stage Parkinson's Disease"

PHASE3CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

July 31, 1999

Study Completion Date

July 31, 2005

Conditions
Parkinson Disease
Interventions
DRUG

apomorphine HCl injection

Trial Locations (1)

26505

Mylan Pharmaceuticals, Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Bertek Pharmaceuticals

INDUSTRY